Exercise as medicine: can a 12-week program reverse muscle loss in breast cancer survivors?

NCT ID NCT07732101

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether a 12-week structured exercise program, called "Exercise for Muscle Health," can improve muscle mass, strength, and physical function in breast cancer survivors who have sarcopenia—a condition of muscle loss and weakness. About 104 women who have finished primary breast cancer treatment and meet sarcopenia criteria will be randomly assigned to either the exercise program plus health education or routine care with general activity advice. The study measures changes in muscle mass, grip strength, physical performance, and quality of life over several months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 12-week structured exercise program called "Exercise for Muscle Health" combined with health education
What this could lead to
If it works, this could provide an evidence-based exercise program to help breast cancer survivors regain muscle and improve quality of life.
What could go wrong
This is a relatively small trial (104 participants) testing a new program, so results may not apply to all survivors. Exercise programs require adherence, and benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Fifth Medical Center of Chinese PLA General Hospital (South Campus)

    Beijing, Beijing Municipality, 100054, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.